Is the vasculature a potential therapeutic target in arthritis?

Is the vasculature a potential therapeutic target in arthritis?

The vasculature fulfils a gatekeeper role in cell recruitment, through expression of leukocyte activators and chemoattractants, as well as adhesion molecules. Endothelial cells also play a role in the growth of new blood vessels ('angiogenesis'), which are vital for efficient supply of oxy...

Bibliografske podrobnosti
Main Authors:	Taylor, P, Paleolog, E
Format:	Journal article
Izdano:	2006

Podobne knjige/članki

The vasculature in rheumatoid arthritis: cause or consequence?
od: Paleolog, E
Izdano: (2009)

Role of angiogenesis in the pathogenesis of arthritis: Potential therapeutic applications
od: Kiriakidis, S, et al.
Izdano: (2011)

A window on disease pathogenesis and potential therapeutic strategies: molecular imaging for arthritis.
od: Gompels, L, et al.
Izdano: (2011)

Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience.
od: Thairu, N, et al.
Izdano: (2011)

Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis.
od: Monaco, C, et al.
Izdano: (2004)

Molecular therapeutic targets in rheumatoid arthritis.
od: Sacre, S, et al.
Izdano: (2005)

The Normal and Brain Tumor Vasculature: Morphological and Functional Characteristics and Therapeutic Targeting
od: Joris Guyon, et al.
Izdano: (2021-03-01)

Targeting the vasculature in cardiometabolic disease
od: Nabil E. Boutagy, et al.
Izdano: (2022-03-01)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
od: Taylor, P, et al.
Izdano: (2004)

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?
od: Feldmann, M, et al.
Izdano: (2002)

The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies
od: Zakaria Elias Ileiwat, et al.
Izdano: (2022-08-01)

Angiogenesis in rheumatoid arthritis.
od: Paleolog, E
Izdano: (2002)

4th meeting of the EU research network EUROME: from the identification of genes and cellular networks in murine models of arthritis to novel therapeutic intervention strategies in rheumatoid arthritis, London, UK, 9 March 2004.
od: Ibrahim, S, et al.
Izdano: (2004)

Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.
od: Jin, P, et al.
Izdano: (2008)

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.
od: Shona A Hendry, et al.
Izdano: (2016-12-01)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
od: Taylor, P, et al.
Izdano: (2001)

The Contribution of Macrophage Plasticity to Inflammatory Arthritis and Their Potential as Therapeutic Targets
od: Karina Kulakova, et al.
Izdano: (2024-09-01)

T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
od: Tingting Ding, et al.
Izdano: (2019-11-01)

Immunotherapies targeting tumor vasculature: challenges and opportunities
od: Hassan Dianat-Moghadam, et al.
Izdano: (2023-09-01)

Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
od: Motohiro Nonaka, et al.
Izdano: (2021-01-01)

PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response
od: Arian Ansardamavandi, et al.
Izdano: (2023-11-01)

Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies
od: Itoh, Y
Izdano: (2017)

Potential therapeutic antibodies targeting specific adiponectin isoforms in rheumatoid arthritis
od: Yeon-Ah Lee, et al.
Izdano: (2018-10-01)

The vasoactive potential of kisspeptin-10 in the peripheral vasculature.
od: Iain Sawyer, et al.
Izdano: (2011-02-01)

Targeting polymer coated adenovirus to tumour-associated vasculature
od: Bachtarzi, H
Izdano: (2010)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
od: Jieying Yang, et al.
Izdano: (2023-04-01)

Targeting the tumor vasculature with engineered cystine-knot miniproteins
od: Bonny Gaby Lui, et al.
Izdano: (2020-01-01)

Targeting the vasculature to improve neural progenitor transplant survival
od: Hill Justin, et al.
Izdano: (2015-01-01)

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
od: Alessandro Ruggiero, et al.
Izdano: (2010-09-01)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
od: Fen Zhang, et al.
Izdano: (2023-10-01)

Identification of lamprey variable lymphocyte receptors that target the brain vasculature
od: Jason M. Lajoie, et al.
Izdano: (2022-04-01)

Meningeal lymphatic vasculature, a general target for glioblastoma therapy?
od: Changping Zhou, et al.
Izdano: (2024-03-01)

Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
od: Melissa C Paoloni, et al.
Izdano: (2009-01-01)

VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis.
od: Etherington, P, et al.
Izdano: (2002)

Hypoxia-driven angiogenesis is a key feature of tendon disease in rheumatoid arthritis
od: Sivakumar, B, et al.
Izdano: (2006)

Retinal vasculature in mammalia
od: Agrawal P, et al.
Izdano: (1968-01-01)

Interaction Between Blood Vasculatures and Lymphatic Vasculatures During Inflammation
od: Wang SS, et al.
Izdano: (2023-08-01)

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.
od: Konisti, S, et al.
Izdano: (2012)

Targeting Neutrophil Extracellular Traps in Gouty Arthritis: Insights into Pathogenesis and Therapeutic Potential
od: Li C, et al.
Izdano: (2024-03-01)

Dysregulation of lncRNAs in Rheumatoid Arthritis: Biomarkers, Pathogenesis and Potential Therapeutic Targets
od: Chenggui Miao, et al.
Izdano: (2021-03-01)